# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Looking at Q3, Cantel Medical (NYSE:CMD) earned $45.52 million, a 43.93% increase from the preceding quarter. Cantel Medical a...
Looking at Q3, Cantel Medical (NYSE:CMD) earned $45.52 million, a 43.93% increase from the preceding quarter. Cantel Medical al...
Cantel Medical (NYSE:CMD) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.50 by ...
Companies Reporting Before The Bell • Barnes & Noble Education (NYSE:BNED) is expected to report quarterly loss at $0.3...
Cantel Medical (NYSE:CMD) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's everything-that-m...
Needham analyst Mike Matson downgrades Cantel Medical (NYSE:CMD) from Buy to Hold.
On Tuesday morning, 323 companies hit new 52-week highs.
Complementary to STERIS's product and service portfolio, focused on infection prevention Extends STERIS's reach t...